Novel application of stem cell-derived neurons to evaluate the time- and dose-dependent progression of excitotoxic injury

• Published in: PloS one 2013-05, Vol.8 (5), p.e64423
• Main Authors: Gut, Ian M, Beske, Phillip H, Hubbard, Kyle S, Lyman, Megan E, Hamilton, Tracey A, McNutt, Patrick M
• Format: Article
• Language: English
• Subjects: Amino acids; Animals; Antagonists; Apoptosis; Biology; Calcium; Calcium - metabolism; Cell culture; Cell death; Cell Line; Data processing; Degeneration; Dose-Response Relationship, Drug; Electron microscopy; Electrophysiological Phenomena - drug effects; Electrophysiology; Embryo cells; Embryonic stem cells; Excitation; Excitotoxicity; Gene Expression Regulation - drug effects; Glutamate; Glutamatergic transmission; Glutamates - toxicity; Glutamic acid receptors; Health aspects; Humans; Immunocytochemistry; Internalization; Ischemia; Magnesium; Medical research; Medicine; Mice; Molecular modelling; N-Methyl-D-aspartic acid receptors; Neurodegeneration; Neurons; Neurons - cytology; Neurons - drug effects; Neurons - metabolism; Neuroprotection; Neurotoxicity; Neurotoxins - toxicity; Pharmacology; Proteomics; Rats; Receptors, N-Methyl-D-Aspartate - metabolism; Rodents; Scanning electron microscopy; Scanning transmission electron microscopy; Stem cell research; Stem cells; Stem Cells - cytology; Time Factors; Toxicity; Transcription, Genetic - drug effects; Yang, Cindy
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0064423

Glutamate receptor (GluR)-mediated neurotoxicity is implicated in a variety of disorders ranging from ischemia to neural degeneration. Under conditions of elevated glutamate, the excessive activation of GluRs causes internalization of pathologic levels of Ca(2+), culminating in bioenergetic failure, organelle degradation, and cell death. Efforts to characterize cellular and molecular aspects of excitotoxicity and conduct therapeutic screening for pharmacologic inhibitors of excitogenic progression have been hindered by limitations associated with primary neuron culture. To address this, we evaluated glutamate-induced neurotoxicity in highly enriched glutamatergic neurons (ESNs) derived from murine embryonic stem cells. As of 18 days in vitro (DIV 18), ESNs were synaptically coupled, exhibited spontaneous network activity with neurotypic mEPSCs and expressed NMDARs and AMPARs with physiological current:voltage behaviors. Addition of 0.78-200 μM glutamate evoked reproducible time- and dose-dependent metabolic failure in 6 h, with a calculated EC50 value of 0.44 μM at 24 h. Using a combination of cell viability assays and electrophysiology, we determined that glutamate-induced toxicity was specifically mediated by NMDARs and could be inhibited by addition of NMDAR antagonists, increased extracellular Mg(2+) or substitution of Ba(2+) for Ca(2+). Glutamate treatment evoked neurite fragmentation and focal swelling by both immunocytochemistry and scanning electron microscopy. Presentation of morphological markers of cell death was dose-dependent, with 0.78-200 μM glutamate resulting in apoptosis and 3000 μM glutamate generating a mixture of necrosis and apoptosis. Addition of neuroprotective small molecules reduced glutamate-induced neurotoxicity in a dose-dependent fashion. These data indicate that ESNs replicate many of the excitogenic mechanisms observed in primary neuron culture, offering a moderate-throughput model of excitotoxicity that combines the verisimilitude of primary neurons with the flexibility and scalability of cultured cells. ESNs therefore offer a physiologically relevant platform that exhibits characteristic NMDAR responses, and appears suitable to evaluate molecular mechanisms of glutamate-induced excitotoxicity and screen for candidate therapeutics.